Table 3.
Significance of medical foods in Alzheimer’s disease (AD).
Brand Name | Ingredients | Mechanism of Action | Significance | References |
---|---|---|---|---|
Axona | Caprylic triglyceride |
Caprylic acid to ketone bodies metabolism provided an alternative energy source for neurons with compromised glucose utilization |
Cause significant increase in serum ketone bodies 2 h after administration. A significant difference was found between Axona and placebo groups in mean change from baseline in ADAS-cog score on days 45 and 90 of administration (Axona group improving and controls worsening) |
[28] |
Souvenaid | Omega-3 fatty acids (eicosapentaenoic acid, Docosahexaenoic acid), vitamins B6, B12, C, and E, choline, folic acid, selenium, uridine monophosphate, phospholipids |
Effects on deficits in neuronal membrane composition and function as well as improvement of synapse formation |
A significant improvement was found in delayed verbal recall and unchanged clinical outcomes after daily administration for 12 weeks. |
[121] |
A significant improvement in memory domain function was found and assessed with a neuropsychological test battery |
[123] | |||
CrerefolinNAC | L-methylfolate, methylcobalamin, N-acetyl-cysteine |
Effects on metabolic imbalances and neurovascular oxidative stress in hyper-homocysteinemia |
A significant decrease in hippocampal and cortical atrophy rates were found in participants with both AD and hyperhomocysteinemia |
[122] |